Skip to main content
. 2020 Feb 3;9(6):2153–2159. doi: 10.1002/cam4.2895

Figure 3.

Figure 3

Combination of KrasG12V mutation and regulatory T cells further stratify prognosis in advanced pancreatic cancer patients